Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction.ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity investment…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Leila Ahmed
…
This content is for Standard 1 Year members only. LoginJoin Now